• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Transdermal Drug Delivery Systems Market

    ID: MRFR/Pharma/52257-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Transdermal Drug Delivery Systems Market Research Report By Product (Transdermal Patches, Semisolids) and By Technology (Electric Current, Iontophoresis, Electroporation, Ultrasound, Microporation)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Transdermal Drug Delivery Systems Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    UK Transdermal Drug Delivery Systems Market Summary

    The United Kingdom UK Transdermal Drug Delivery Systems market is projected to grow from 1.32 USD Billion in 2024 to 2 USD Billion by 2035.

    Key Market Trends & Highlights

    UK Transdermal Drug Delivery Systems Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 3.85 percent from 2025 to 2035.
    • By 2035, the market value is anticipated to reach 2 USD Billion, indicating robust growth potential.
    • In 2024, the market valuation stands at 1.32 USD Billion, reflecting a solid foundation for future expansion.
    • Growing adoption of transdermal drug delivery systems due to increasing patient preference for non-invasive administration is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.32 (USD Billion)
    2035 Market Size 2 (USD Billion)
    CAGR (2025-2035) 3.85%

    Major Players

    Teva Pharmaceutical Industries, Galderma, Alza Corporation, Hikma Pharmaceuticals, Corium International, Johnson & Johnson, Nupatch, Boehringer Ingelheim, AstraZeneca, Parker Hannifin, Purdue Pharma, Novartis, Endo Pharmaceuticals, Mylan, Transdermal Technologies

    UK Transdermal Drug Delivery Systems Market Trends

    In the UK, the transdermal drug delivery systems market is experiencing significant growth, driven by the increasing demand for non-invasive methods of drug administration. The convenience and effectiveness of transdermal patches have attracted a wide range of patients, particularly in managing chronic conditions such as pain and hormone replacement therapies. Additionally, the rising prevalence of diabetes has led to a greater focus on transdermal systems for delivering insulin, making this an important consideration in the market.

    The UK government’s initiatives around healthcare innovation are also fostering a more favorable environment for the development of advanced transdermal technologies, as they aim to improve patient care and medication adherence.

    There are several potential to be explored in the United Kingdom, particularly the integration of digital health solutions with transdermal systems. For example, smart transdermal patches with monitoring capabilities can deliver real-time data to healthcare providers, improving patient management and outcomes. Companies that specialize in designing solutions for certain patient populations, such as the elderly or pediatric patients, can also tap into a burgeoning market sector seeking more personalized drug delivery options. Recent trends in the UK show a great interest in research and development of innovative formulations and technologies aimed at improving the efficacy and comfort of transdermal systems.

    The integration of biodegradable materials into patch designs is gaining traction as sustainability becomes a critical concern among healthcare stakeholders. Additionally, the collaboration between pharmaceutical companies and technology firms is emerging as a trend, enabling the development of innovative products that cater to evolving patient needs in the UK healthcare landscape. Overall, the UK transdermal drug delivery systems market is set for continued evolution, with a focus on patient-centered solutions and advanced technological integration.

    UK Transdermal Drug Delivery Systems Market Drivers

    Market Segment Insights

    Transdermal Drug Delivery Systems Market Product Insights

    The UK Transdermal Drug Delivery Systems Market showcases a variety of products, with notable emphasis on Transdermal Patches and Semisolids, both of which play crucial roles in this evolving market. Transdermal Patches have garnered significant attention due to their user-friendly application and ability to provide consistent drug delivery over extended periods. This method minimizes the issues associated with oral drug forms, such as gastrointestinal degradation and first-pass metabolism, enhancing therapeutic effectiveness. Additionally, the rise in chronic diseases requiring long-term medication and a growing preference for non-invasive administration methods bolster the demand for Transdermal Patches.

    On the other hand, Semisolids represent an essential aspect of delivering therapeutics, as they offer flexibility and adaptability in formulation. They are particularly advantageous for localized treatment, ensuring that the drug can be applied directly to the affected area. The increasing focus on personalized medicine further underscores the potential of these formulations, as they can be tailored to meet specific patient needs.

    Overall, the segmentation within the UK Transdermal Drug Delivery Systems Market reflects a dynamic landscape driven by a combination of innovative technologies and changing patient preferences, with both Transdermal Patches and Semisolids holding substantial significance in fostering advancements in drug delivery solutions.The integration of robust Research and Development initiatives across these product categories also signals a promising trajectory for the industry as it seeks to enhance efficacy and patient adherence.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Transdermal Drug Delivery Systems Market Technology Insights

    The Technology segment of the UK Transdermal Drug Delivery Systems Market plays a crucial role in shaping the future of drug administration methods. Among its various segments, Electric Current, Iontophoresis, Electroporation, Ultrasound, and Microporation are significant for their efficiency in enhancing drug permeability through the skin. Iontophoresis employs electrical currents to facilitate drug delivery, while Electroporation uses short pulses of electric fields, allowing larger molecules to penetrate the skin barrier. Ultrasound technology, meanwhile, leverages sound waves to improve drug absorption, appealing particularly to patients who may have difficulty swallowing pills.

    Microporation offers a minimally invasive option, creating micro-channels in the skin to enable drug absorption effectively. The rising preference for non-invasive therapies and increasing incidences of chronic diseases in the UK boost demand for these advanced delivery methods. Furthermore, advancements in technology, including automation and improved drug formulations, are expected to drive innovations in this sector, leading to better patient outcomes and higher adoption rates across healthcare settings. As the UK places a strong focus on patient-centered care, these technologies offer promising solutions to enhance the efficacy and convenience of drug delivery.

    Get more detailed insights about UK Transdermal Drug Delivery Systems Market Research Report - Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The UK Transdermal Drug Delivery Systems Market is characterized by a diverse landscape where innovation meets demand for effective and non-invasive drug administration methods. This sector has gained momentum due to rising healthcare costs, an increasing emphasis on pain management, and growing consumer preference for painless drug delivery modes. Companies operating in this space are continuously striving to enhance their technological capabilities and expand their product portfolios. Moreover, strategic partnerships, mergers, and acquisitions are common as organizations aim to leverage synergies that can lead to improved product development and market penetration.

    Given the competitive nature of the market, firms also focus on regulatory compliance and maintaining high-quality manufacturing processes to ensure they adhere to stringent health and safety standards, all while responding to the dynamic needs of patients and healthcare providers alike.

    Teva Pharmaceutical Industries holds a significant position in the UK Transdermal Drug Delivery Systems Market, leveraging its extensive experience and expertise in pharmaceuticals. Teva is recognized for its commitment to quality and innovation, offering a range of transdermal products that cater to various therapeutic areas such as pain management and hormone replacement. Its strength lies in its robust research and development capabilities which allow Teva to continuously introduce new formulations and improve existing ones. Additionally, the company's extensive distribution network and relationship with healthcare practitioners enable it to effectively meet patient needs across the UK.

    By focusing on strategic collaborations and enhancing its product visibility, Teva has successfully established a strong foothold in a competitive landscape.

    Galderma is another key player in the UK Transdermal Drug Delivery Systems Market, known primarily for its dermatological products, which include transdermal delivery systems designed for effective treatment of skin conditions. The company's strong market presence is bolstered by its focus on innovation and a commitment to high-quality standards, addressing critical needs in dermatology with specialized solutions. Galderma's strengths lie in its deep expertise in skin health and the development of products that enhance therapeutic efficacy while ensuring patient comfort.

    The company actively engages in strategic partnerships and has pursued mergers and acquisitions to reinforce its market position and broaden its product range, enabling quicker access to new technologies and a more diverse offering in the UK market. Key products from Galderma ensure compliance with regulatory standards while addressing specific patient and practitioner demands, thereby enhancing its appeal within the transdermal market space.

    Key Companies in the UK Transdermal Drug Delivery Systems Market market include

    Industry Developments

    The UK Transdermal Drug Delivery Systems Market has seen several notable developments in recent months. Teva Pharmaceutical Industries and Galderma are focusing on expanding their product lines to meet growing demand for non-invasive delivery systems, while Johnson and Johnson have recently launched an innovative patch aimed at enhancing the efficacy of pain management therapies. In terms of market dynamics, the industry has been witnessing significant growth attributed to an increase in chronic diseases and a rising preference for pain management solutions that are more patient-friendly.

    In July 2023, AstraZeneca announced plans to collaborate with Transdermal Technologies to develop a new formulation of transdermal patches, aiming to improve drug absorption. Notably, Hikma Pharmaceuticals has reported a 15% rise in revenue for its transdermal division, reflecting the overall positive growth trajectory in the market. In recent years, particularly since August 2021, there's been an increased focus on regulatory frameworks to accelerate the approval of transdermal systems, enhancing the competitive landscape for companies such as Purdue Pharma and Novartis.

    The market is poised for further advancements as firms continue to innovate and respond to consumer and healthcare needs in the UK.

    Market Segmentation

    Transdermal Drug Delivery Systems Market Product Outlook

    • Transdermal Patches
    • Semisolids

    Transdermal Drug Delivery Systems Market Technology Outlook

    • Electric Current
    • Iontophoresis
    • Electroporation
    • Ultrasound
    • Microporation

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 1.26(USD Billion)
    MARKET SIZE 2024 1.32(USD Billion)
    MARKET SIZE 2035 2.0(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 3.82% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Teva Pharmaceutical Industries, Galderma, Alza Corporation, Hikma Pharmaceuticals, Corium International, Johnson & Johnson, Nupatch, Boehringer Ingelheim, AstraZeneca, Parker Hannifin, Purdue Pharma, Novartis, Endo Pharmaceuticals, Mylan, Transdermal Technologies
    SEGMENTS COVERED Product, Technology
    KEY MARKET OPPORTUNITIES Increasing demand for non-invasive methods, Growing prevalence of chronic diseases, Advancements in drug formulation technologies, Expanding aging population requiring medication, Rising focus on patient adherence solutions
    KEY MARKET DYNAMICS Growing prevalence of chronic diseases, Increasing demand for pain management, Advancements in drug formulation technology, Rising preference for non-invasive methods, Favorable government regulations
    COUNTRIES COVERED UK

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the projected market size of the UK Transdermal Drug Delivery Systems Market by 2035?

    The UK Transdermal Drug Delivery Systems Market is expected to be valued at 2.0 USD Billion by the year 2035.

    What was the market size of the UK Transdermal Drug Delivery Systems Market in 2024?

    In 2024, the market size of the UK Transdermal Drug Delivery Systems Market is projected to be 1.32 USD Billion.

    What is the expected compound annual growth rate (CAGR) for the UK Transdermal Drug Delivery Systems Market from 2025 to 2035?

    The expected CAGR for the UK Transdermal Drug Delivery Systems Market from 2025 to 2035 is 3.82%.

    How is the UK Transdermal Drug Delivery Systems Market divided by product segments?

    The UK Transdermal Drug Delivery Systems Market is divided into Transdermal Patches and Semisolids.

    What is the estimated market value for Transdermal Patches in 2035?

    The estimated market value for Transdermal Patches in 2035 is 1.2 USD Billion.

    What is the market value for Semisolids in the UK Transdermal Drug Delivery Systems Market in 2024?

    The market value for Semisolids in 2024 is expected to be 0.52 USD Billion.

    Who are the major players in the UK Transdermal Drug Delivery Systems Market?

    Key players in the market include Teva Pharmaceutical Industries, Johnson & Johnson, and AstraZeneca among others.

    What are the anticipated growth drivers for the UK Transdermal Drug Delivery Systems Market?

    The market is driven by the rising demand for non-invasive drug delivery solutions and advancements in patch technology.

    What challenges does the UK Transdermal Drug Delivery Systems Market face?

    Challenges include regulatory hurdles and the need for continuous innovation in drug formulation technologies.

    What is the projected market share of Semisolids by 2035?

    By 2035, the market value for Semisolids is expected to reach 0.8 USD Billion.

    1. SUMMARY Market OverviewKey FindingsMarket SegmentationCompetitive LandscapeChallenges and
    2. OpportunitiesFuture Outlook  MARKET INTRODUCTION DefinitionScope of the studyResearch
    3. ObjectiveAssumptionLimitationsRESEARCH
    4. METHODOLOGY OverviewData MiningSecondary
    5. ResearchPrimary ResearchPrimary Interviews and Information
    6. Gathering ProcessBreakdown of Primary RespondentsForecasting
    7. ModelMarket Size EstimationBottom-Up ApproachTop-Down
    8. ApproachData TriangulationValidation  MARKET
    9. DYNAMICS OverviewDriversRestraintsOpportunitiesMARKET FACTOR ANALYSIS Value chain AnalysisPorter's
    10. Five Forces AnalysisBargaining Power of SuppliersBargaining
    11. Power of BuyersThreat of New EntrantsThreat of SubstitutesIntensity
    12. of RivalryCOVID-19 Impact AnalysisMarket
    13. Impact AnalysisRegional ImpactOpportunity and Threat
    14. Analysis  UK
    15. Transdermal Drug Delivery Systems Market, BY Product (USD Billion) Transdermal
    16. PatchesSemisolidsUK Transdermal
    17. Drug Delivery Systems Market, BY Technology (USD Billion) Electric
    18. CurrentIontophoresisElectroporationUltrasoundMicroporation  Competitive Landscape OverviewCompetitive AnalysisMarket
    19. share AnalysisMajor Growth Strategy in the Transdermal Drug Delivery
    20. Systems MarketCompetitive BenchmarkingLeading Players
    21. in Terms of Number of Developments in the Transdermal Drug Delivery Systems MarketKey
    22. developments and growth strategiesNew Product Launch/Service DeploymentMerger
    23. & AcquisitionsJoint VenturesMajor
    24. Players Financial MatrixSales and Operating IncomeMajor
    25. Players R&D Expenditure. 2023Company
    26. Profiles Teva Pharmaceutical IndustriesFinancial
    27. OverviewProducts OfferedKey DevelopmentsSWOT
    28. AnalysisKey StrategiesGaldermaFinancial
    29. OverviewProducts OfferedKey DevelopmentsSWOT
    30. AnalysisKey StrategiesAlza CorporationFinancial
    31. OverviewProducts OfferedKey DevelopmentsSWOT
    32. AnalysisKey StrategiesHikma PharmaceuticalsFinancial
    33. OverviewProducts OfferedKey DevelopmentsSWOT
    34. AnalysisKey StrategiesCorium InternationalFinancial
    35. OverviewProducts OfferedKey DevelopmentsSWOT
    36. AnalysisKey StrategiesJohnson & JohnsonFinancial
    37. OverviewProducts OfferedKey DevelopmentsSWOT
    38. AnalysisKey StrategiesNupatchFinancial
    39. OverviewProducts OfferedKey DevelopmentsSWOT
    40. AnalysisKey StrategiesBoehringer IngelheimFinancial
    41. OverviewProducts OfferedKey DevelopmentsSWOT
    42. AnalysisKey StrategiesAstraZenecaFinancial
    43. OverviewProducts OfferedKey DevelopmentsSWOT
    44. AnalysisKey StrategiesParker HannifinFinancial
    45. OverviewProducts OfferedKey DevelopmentsSWOT
    46. AnalysisKey StrategiesPurdue PharmaFinancial
    47. OverviewProducts OfferedKey DevelopmentsSWOT
    48. AnalysisKey StrategiesNovartisFinancial
    49. OverviewProducts OfferedKey DevelopmentsSWOT
    50. AnalysisKey StrategiesEndo PharmaceuticalsFinancial
    51. OverviewProducts OfferedKey DevelopmentsSWOT
    52. AnalysisKey StrategiesMylanFinancial
    53. OverviewProducts OfferedKey DevelopmentsSWOT
    54. AnalysisKey StrategiesTransdermal TechnologiesFinancial
    55. OverviewProducts OfferedKey DevelopmentsSWOT
    56. AnalysisKey StrategiesAppendix
    57. ReferencesRelated ReportsLIST
    58. Of tables LIST OF ASSUMPTIONSUK Transdermal
    59. Drug Delivery Systems Market SIZE ESTIMATES & FORECAST, BY PRODUCT, 2019-2035
    60. (USD Billions)UK Transdermal Drug Delivery Systems Market SIZE ESTIMATES
    61. & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)PRODUCT LAUNCH/PRODUCT
    62. DEVELOPMENT/APPROVALACQUISITION/PARTNERSHIP                             LIST
    63. Of figures MARKET SYNOPSISUK TRANSDERMAL
    64. DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY PRODUCTUK TRANSDERMAL DRUG
    65. DELIVERY SYSTEMS MARKET ANALYSIS BY TECHNOLOGYKEY BUYING CRITERIA
    66. OF TRANSDERMAL DRUG DELIVERY SYSTEMS MARKETRESEARCH PROCESS OF MRFRDRO
    67. ANALYSIS OF TRANSDERMAL DRUG DELIVERY SYSTEMS MARKETDRIVERS IMPACT
    68. ANALYSIS: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKETRESTRAINTS IMPACT
    69. ANALYSIS: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKETSUPPLY / VALUE
    70. CHAIN: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKETTRANSDERMAL DRUG
    71. DELIVERY SYSTEMS MARKET, BY PRODUCT, 2025 (% SHARE)TRANSDERMAL DRUG
    72. DELIVERY SYSTEMS MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)TRANSDERMAL
    73. DRUG DELIVERY SYSTEMS MARKET, BY TECHNOLOGY, 2025 (% SHARE)TRANSDERMAL
    74. DRUG DELIVERY SYSTEMS MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)BENCHMARKING
    75. OF MAJOR COMPETITORS 

    UK Transdermal Drug Delivery Systems Market Segmentation

     

     

     

    • Transdermal Drug Delivery Systems Market By Product (USD Billion, 2019-2035)

      • Transdermal Patches
      • Semisolids

     

    • Transdermal Drug Delivery Systems Market By Technology (USD Billion, 2019-2035)

      • Electric Current
      • Iontophoresis
      • Electroporation
      • Ultrasound
      • Microporation

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials